Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Metastatic Breast Cancer
Interventions: DRUG: ribociclib|DRUG: letrozole|DRUG: goserelin
Sponsor: Novartis Pharmaceuticals